Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C

被引：0

作者：

Angela Costantino

Enea Spada

Michele Equestre

Roberto Bruni

Elena Tritarelli

Nicola Coppola

Caterina Sagnelli

Evangelista Sagnelli

Anna Rita Ciccaglione

机构：

[1] Department of Infectious,Department of Mental Health and Public Medicine, Section of Infectious diseases

[2] Parasitic and Immune-Mediated Diseases,Department of Experimental Medicine and Surgery F. Magrassi and A. Lanzara

[3] Viral Hepatitis Unit,undefined

[4] Istituto Superiore di Sanità,undefined

[5] Department of Cell Biology and Neurosciences,undefined

[6] Istituto Superiore di Sanità,undefined

[7] Second University of Naples,undefined

[8] Second University of Naples,undefined

来源：

Virology Journal | / 12卷

关键词：

Hepatitis C virus; Mutations; Antiviral treatment; Genotype; Italy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naive patients with chronic hepatitis C
Costantino, Angela
Spada, Enea
Equestre, Michele
Bruni, Roberto
Tritarelli, Elena
Coppola, Nicola
Sagnelli, Caterina
Sagnelli, Evangelista
Ciccaglione, Anna Rita
VIROLOGY JOURNAL, 2015, 12
[2] Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naïve patients
Stefania Paolucci
Loretta Fiorina
Bianca Mariani
Roberto Gulminetti
Stefano Novati
Giorgio Barbarini
Raffaele Bruno
Fausto Baldanti
Virology Journal, 10
[3] The prevalence of naturally occurring resistance mutations against NS3 protease inhibitors, NS5A replication complex inhibitors, and NS5B polymerase inhibitors in patients with hepatitis C virus genotype 1b
Hayashi, Kazuhiko
Ishigami, Masatoshi
Ishizu, Yoji
Kuzuya, Teiji
Honda, Takashi
Katano, Yoshiaki
Hirooka, Yoshiki
Goto, Hidemi
HEPATOLOGY, 2014, 60 : 896A - 897A
[4] Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
Stefania Paolucci
Loretta Fiorina
Antonio Piralla
Roberto Gulminetti
Stefano Novati
Giorgio Barbarini
Paolo Sacchi
Marta Gatti
Luca Dossena
Fausto Baldanti
Virology Journal, 9
[5] Drug resistance mutations in the HCV NS3 protease and NS5B polymerase in newly diagnosed HIV-1 patients with chronic hepatitis C in Spain
Trevino, A.
de Mendoza, C.
Parra, P.
Rodriguez, C.
Madejon, A.
Plaza, Z.
del Romero, J.
Poveda, E.
Soriana, V.
ANTIVIRAL THERAPY, 2010, 15 : A115 - A115
[6] Naturally occurring resistance mutations to inhibitors of HCV NS5A region and NS5B polymerase in DAA treatment-naive patients
Paolucci, Stefania
Fiorina, Loretta
Mariani, Bianca
Gulminetti, Roberto
Novati, Stefano
Barbarini, Giorgio
Bruno, Raffaele
Baldanti, Fausto
VIROLOGY JOURNAL, 2013, 10
[7] Prevalence of NS5B resistance-associated variants in treatment-naïve Asian patients with chronic hepatitis C
Song Yang
Huichun Xing
Shenghu Feng
Wei Ju
Shunai Liu
Xiaomei Wang
Weini Ou
Jun Cheng
Calvin Q. Pan
Archives of Virology, 2018, 163 (2) : 467 - 473
[8] A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors
Chase, Robert
Skelton, Angela
Xia, Ellen
Curry, Stephanie
Liu, Shaotang
McMonagle, Patricia
Huang, H. -C.
Tong, Xiao
ANTIVIRAL RESEARCH, 2009, 84 (02) : 178 - 184
[9] NATURALLY OCCURRING DRUG RESISTANCE MUTATIONS IN THE HEPATITIS C VIRUS NS3 PROTEASE IN HIV/HCV COINFECTED PATIENTS TREATED WITH HIV PROTEASE INHIBITORS
Bottecchia, M.
Madejon, A.
Sanchez-Carillo, M.
Labarga, P.
Garcia-Samaniego, J.
Soriano, V.
JOURNAL OF HEPATOLOGY, 2010, 52 : S289 - S289
[10] Mutations in hepatitis C virus NS3 protease domain associated with resistance to specific protease inhibitors in antiviral therapy naïve patients
Allan Peres-da-Silva
Adilson José de Almeida
Elisabeth Lampe
Archives of Virology, 2010, 155 : 807 - 811

← 1 2 3 4 5 →